contractility, increases the production of vascular Nitric Oxide (NO) 8 and prostacyclin. Calcium might also have an indirect effect on smooth muscle function by increasing magnesium levels 9 .
By reducing uterine smooth muscle contractility it prevents preterm labour 10 .
Prevention of Preeclampsia would be a great step forward in prenatal care. One such primary prevention is oral supplementation of high dose calcium(2gm/ day) after 20 weeks of pregnancy.
This study was undertaken to evaluate the effect of high dose (2gm) calcium in reducing incidence of preeclampsia in women at high risk of preeclampsia.
Materials and Methods:
A prospective randomized clinical trial on 272 healthy nulliparous women were randomly allocated into two groups by computer generation randomization table. From 20 weeks of gestation until delivery 127 were assigned to high dose calcium group or the study group who received 2 gm of oral elemental calcium (4 tablets of 500 mg each) per day and 145 women were assigned to low dose calcium or control groups , receiving 500 mg of calcium(one active calcium tablet of 500 mg and 3 placebo tablets of the same size, weight, and colours the calcium tablets) per day. Ten women (3.67%) were lost to follow up after randomization (4 in the study group and 6 in the control group. Thus a total of 123 woman in the study group and 139 in the control group were included in the final analysis. • Serum urea, creatinine, uric acid estimation • Liver function test.
• Bleeding time (BT), Clotting time (CT), and platelet count.
• Ophthalmoscopic examination for Retinal changes.
The following parameters were noted in the next all visits -• BP • Body weight • Hb %, BT, CT, platelet count.
• Routine urine examination specially albumin.
• Serum and urinary calcium level.
• USG at 20 weeks, 32 weeks, 36 weeks • Retinal changes.
• Serum uric acid.
• Liver function test.
• Any medical problems etc.
Plan for Analysis of Data :
Data were analyzed with SPSS 9 statistical software. Results were presented as mean ± SD, comparison between the groups were analyzed by unpaired student's t test. The Chi-square analysis was done where appropriate and P<0.05 was considered as statistically significant Table I showed 5.7% and 13.7% cases of preeclampsia developed in the study group and the control group respectively. This difference was statistically significant (Chi-squares -4.65, df =1, p = 0.031). 
Results:

Table-II Eclampsia detected among Pre eclamptic mothers both in study and Control Group
Study Groupn=7
Control Groupn=19
Eclampsia 2 (28.57%) 7 (36.84%) 
Discussion:
The randomized control trial shows that supplementation of 2 gm calcium per day decreases the incidence of hypertensive disorders in pregnancy Kumar A. et al. 11 reported that the overall incidence of preeclampsia was 7.8% (41 of 524 women) and the incidence was 4.0% in the calcium group and 12.0% in the placebo group (OR, 0.31; 95% CI, 0.15-0.63). A 66.7% reduction in preeclampsia was observed in the calcium group.
The above report corroborated with our study (Chisquares -4.65, df =1, p = 0.031 , Table 1 )and there was 58.39% reduction of preeclampsia in the present study which nearly corresponds to the study by Kumar A. et al. Kumar A. et al. 11 also reported that none of the women in either group (calcium and placebo group) developed eclampsia, but our study does not correlate well with their study because eclampsia detected in control and study group were 36.84% and 28.57% respectively (Table2)
In the present study, it was noted that 2.43% preterm delivery was in study group and 7.91% in control group (p = 0.04) and there is 69.27% reduction of preterm delivery (table-3) which is more significant than other study 11 .
The mean birth weight was significantly greater in the study group (2900 ± 313.48) than control group (2775 ± 277.69) (p = 0.038). The incidence of IUGR was more higher in control group when compared to study group (9.35% and 3.25% respectively) (p = 0.045). Stillbirths were also reduced in study group (2.43%) than control group (5.03%) (p = 0.27) Herrera JA et al. 12 reported that mean birth weight was significantly greater in the calcium group (2979 ± 448 g) than placebo group (2705 ± 433g), and the difference was statistically significant, p < 0.01. 13 the infants born in the calcium supplemented group had on an average of 500 g or more weight at birth than infant from the placebo group ( infant birth weight for calcium group was 3316 ± 308g and Placebo group was 2764 ± 761 g, the difference was statistically significant < 0.05 ).
According to Niromanesh S et al
So, our study also corroborated to the above two studies. The mean birth weight was significantly greater in the study group (2900 ± 313.48 g) when compared to control group (2775 ± 277.69 g), and p = 0.038. 12 reported that mean maternal diastolic blood pressure at delivery was significantly higher in the placebo group (p =0.005).
Herrera JA et al
We found that Diastolic Blood Pressure (DBP, mmHg) in study and control group were 81.44 ± 8.65 and 83.94 ± 12.54 respectively ( p = 0.0009) and both were almost similar.
So calcium supplementation in high dosage is very popular for reduction of incidence of preeclampsia and chances of renal stone formation is less as the duration of supplementation is short.
Conclusion:
In the light of our observation, calcium intake is beneficial for both pregnant women and their unborn child. Daily supplementation with 2 grams of calcium during pregnancy significantly reduced the risk of preeclampsia, preterm labor and IUGR. So, high dose calcium should be supplemented to all women during pregnancy in developing countries where preeclampsia and preeclampsia related morbidities and mortality are quite high.
